Fluphenazine Hcl
Brand name: Fluphenazine Hcl
Rank #461 of 500 drugs by total cost
$16.0M
Total Cost
73,051
Total Claims
$16.0M
Total Cost
2,824
Prescribers
$220
Cost per Claim
1,430
Beneficiaries
77,721
30-Day Fills
$5,679
Avg Cost/Provider
26
Avg Claims/Provider
About Fluphenazine Hcl
Fluphenazine Hcl (sold as Fluphenazine Hcl) was prescribed 73,051 times by 2,824 Medicare Part D providers in 2023, costing the program $16.0M. At $220 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology